PhAST Corp. is developing a rapid diagnostic technology that utilizes single-cell imaging to provide real-time, actionable data about microorganisms. This innovative approach focuses on closely analyzing individual cells to enhance the speed and accuracy of pathogen detection and antibiotic susceptibility testing.

• ·Single-cell imaging for precise analysis
• ·Real-time diagnostic results
• ·Enhanced speed for faster clinical decision-making
• ·Supports antibiotic susceptibility testing